Posters / Best of the Best and Fast Forward Session

Abstract submissions for:
1. Posters and
2. Posters and oral presentations (Best of the Best and Fast Forward)*
are being accepted into the 2020 meeting program.
Please submit your abstract via the online abstracts portal:
https://events.catalystevents.com.au/eSites/agitgasm2020/Homepage

NOTE:

• In addition to a Poster, your abstract may be selected as an oral presentation in the Annual Scientific Meeting Program (by invitation of the Executive Organising Committee).
• You will be able to indicate if you would like to be considered for an oral presentation during the abstracts submission process.
• For your abstract to be accepted you must be a registered and fully paid delegate. However, you will be able to register and pay once you have been notified of your Abstract’s acceptance.
• You must consent to your abstract being published.
• Industry studies need to be presented by an AGITG clinician and have had significant involvement of the AGITG clinician.
• Encore abstracts will be accepted, provided they meet all the other criteria listed above.

SUBMISSION PROCESS

BEFORE YOU START
During the abstract submission process you will be asked:
• For your name and organisation, as the presenting author.
• For your biography and photograph, as the presenting author. These will be included in the Meeting APP.
• For the name/s and organisation/s of any co-authors – to allow accurate indexing of all authors in the abstract book.
• If you wish to be considered for:
a poster only
or
a poster and oral presentation (Best of the Best and Fast Forward presentations are by invitation only, and made by the Executive Organising Committee, subject to available space in the Program).
• For a title for your abstract.
• For the text of your abstract – which you will be able to copy and paste in – this should be strictly no more than 350 words.
• Images and tables will not be accepted.

ACCEPTANCE PROCESS:

• Notification of programming decisions will come from the secretariat shortly on 1st June 2020 and the working program will be posted to the web site.
• The notification will include specific presentation instructions but in the interim:

Those preparing posters should note the maximum size allowed is 100cm wide by 120cm high (portrait). Velcro will be available to fix the poster to the boards.
Computer data projection is the preferred presentation method for Fast Forward Presentations.

ONLINE SUBMISSION OF YOUR ABSTRACT

When you are ready to submit your abstract please, click here:

https://events.catalystevents.com.au/eSites/agitgasm2020/Homepage

PLEASE NOTE

      • The first time you visit the on-line abstract submission site, you will need to create your ‘My Profile’.
      • Once you have created your ‘My Profile’ you can return to this tab, or log back in with your email and password and return to this tab, to amend any of your contact details.
      • You will then be able to Login to the on-line abstract submission site to add a submission.
      • In the Submissions Tab you will be able to submit a new abstract, or view an existing abstract that has been submitted.  You will be able to click the ‘save and continue later’ button to save your incomplete submission and return to it at a later time by logging back in with your email address and password.
      • Once all required sections have been completed, you can ‘save and submit’ your abstract.
      • At the end of the on-line submission process, you will receive an email.  Please ensure that you receive this, to confirm we have received your abstract. If you do not receive an email, please: a) check in your spam folder, b) contact our Conference Secretariat at agitgasm@catalystevents.com.au or on 02 9419 4889.
      • Should you wish to make changes to your abstract after you have submitted it, please log back into the online abstract process with your email and password, and you will be able to edit an existing, or submit a new abstract.
      • If you encounter any difficulties at any stage, please do not hesitate to contact our Conference Secretariat at agitgasm@catalystevents.com.au or on 02 9419 4889

See below for details of past Award recipients.

 

Best of Posters Awards 2019

2019 Winner – Best of Posters

The winner of the 2019 Best of Posters was presented to Dr Swetha Sridharan, for ‘Palliative Oesophageal Chemoradiotherapy: A Phase I Clinical Trial. Dr Sridharan received $3,500 and a framed certificate.

2019 WINNER – FAST FORWARD

Dr Simon Wilkins was awarded the Best Fast Forward Presentation award for ‘The effect of oversewing double stapled anastomoses in oncological colorectal surgery’. Dr Wilkins receives $1,500 and a framed certificate.

2019 Sponsor

The 2019 Best of Posters Award is proudly supported by GenesisCare.
Best of Posters Awards 2018

2018 Sponsor

The 2018 Best of Posters Award was proudly supported by Clinical Genomics.

2018 Winner – Best of Posters

The winner of the 2018 Best of Posters was Dr Belinda Lee of Walter and Eliza Hall Institute for ‘Pancreatic Cancer: An analysis of 'Real-World' stent-related morbidity in the palliative setting’. Dr Lee received $3,500 and a framed certificate.

2018 Winner – Fast Forward

Dr Hui-Li Wong of the Walter and Eliza Hall Institute was this year’s Fast Forward winner for ‘Biomarker testing and biomarker-directed treatment utilisation for metastatic colorectal cancer in Australian practice’.
Best of Posters Awards 2017
Ipsen

2017 Sponsor

The 2017 Best of Posters Award was proudly supported by Ipsen.
Dr Mooi

2017 Winner – Best of Posters

The winner of the 2017 Best of Posters was Dr Jennifer Mooi of the Olivia Newton-John Cancer Research Institute for ‘Exploring Consensus Molecular Subtypes (CMS) as predictors of benefit from bevacizumab in first line treatment of metastatic colorectal cancer: retrospective analysis of the MAX clinical trial’. Dr Mooi receives $3,500 and a framed certificate.
2017 Runner Up – Best of Posters

2017 Runner Up – Best of Posters

The runner-up of the Best of Posters was Dr Margaret Lee of the Walter and Eliza Hall Institute VIC for her poster and oral presentation ‘The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC)’.  Dr Lee receives $1,500 and a framed certificate.
Dr Melanie McCoy

2017 Winner – Fast Forward

Dr Melanie McCoy was this year’s Fast Forward winner for ‘The Cancer Stem-Like Cell Marker SOX2 is Prognostic and May Predict Response to Chemotherapy in Colon Cancer’.
Best of Posters Awards 2016
Ipsen

2016 Sponsor

The 2016 Best of Posters Award was proudly supported by Ipsen.
Sharon Pattison - 2016 Poster Winner

2016 Winner – Best of Posters

The winner of the 2016 Best of Posters was Sharon Pattison of University of Otago for ‘Mismatch repair deficiency, inflammatory score and prognosis in gastric cancer’. The runner up was Melanie McCoy, St John of God Hospital Subiaco for ‘Immune biomarkers of response to chemoradiotherapy in locally advanced rectal cancer’.
Melanie McCoy - 2016 Runner Up Poster

2016 Runner Up – Best of Posters

The runner up was Melanie McCoy, St John of God Hospital Subiaco for ‘Immune biomarkers of response to chemoradiotherapy in locally advanced rectal cancer’.
Best of Posters Awards 2015
Ipsen

2015 Sponsor

The 2015 Best of Posters Award was proudly supported by Ipsen.
Dr Rebecca Tay

2015 Winner – Best of Posters

The Posters Session continued to grow in 2015. Dr Rebecca Tay from Eastern Health was awarded the Best of Posters for her poster entitled "Survival impact of adjuvant chemotherapy for resected early stage rectal adenocarcinoma".
Best of Posters Awards 2014
Ipsen

2014 Sponsor

The 2014 Best of Posters Award was proudly supported by Ipsen.
Dr Matthew Burge

2014 Winner – Best of Posters

Dr Matthew Burge of Royal Brisbane Hospital won the Best Poster Award sponsored by Ipsen. Dr Burge’s poster was entitled: “A prospective, single institution study of the impact of Fluorodeoxyglucose (FDG) positron Emission Tomograpthy with concurrent non-contract CT scanning (PET/CT) on the management of operable Pancreatic, Ampullary or Distal Bile Duct cancer.”